Control of Japanese encephalitis in Asia: the time is now

References

• Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 2011;89:766-774E
   PubMed Web of Science ®Google Scholar
• World Health Organization. Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006;81:325-40
   PubMedGoogle Scholar
• PATH. Japanese encephalitis morbidity, mortality, and disability: reduction and control by 2015. Available from: www.path.org/vaccineresources/files/JE_Reduction_and_Control_by_2015.pdf [Last accessed 21 April 2014]
   Google Scholar
• Kumar R, Tripathi P, Rizvi A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 2009;360:1465-6
   PubMed Web of Science ®Google Scholar
• Gatchalian S, Yao Y, Zhou B, et al. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine 2008;26:2234-41
   PubMed Web of Science ®Google Scholar
• Victor JC, Gatchalian S, Yao Y, et al. Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants”. Vaccine 2014;32:306-3085
   Web of Science ®Google Scholar
• Hennessy S, Liu Z, Tsai TF, et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 1996;347:1583-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization standards. Japanese Encephalitis Vaccine (Live) (1 dose vial). Available from: www.who.int/immunization_standards/vaccine_quality/pq_270_je_1dose_chengdu/en/ [Last accessed 12 May 2014]
   Google Scholar
• Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010;59(1):1-27
   Google Scholar
• Schuller E, Klingler A, Dubischar-Kastner K, et al. Safety profile of the vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO. Vaccine 2011;29:8669-76
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization standards. Japanese encephalitis vaccine (inactivated) (1 dose vial). Available from: www.who.int/immunization_standards/vaccine_quality/pq266_je_1dose_biologicale/en/ [Last accessed 18 April 2014]
   Google Scholar
• Feroldi E, Pancharoen C, Kosalaraksa P, et al. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother 2012;8(7):929-37
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Advisory Committee on Vaccine Safety, 11–12 December 2013. Wkly Epidemiol Rec 2014;89:53-60
   PubMedGoogle Scholar
• Yaïch M. Investing in vaccines for developing countries: how public-private partnerships can confront neglected diseases. Hum Vaccine 2009;5:368-9
   PubMed Web of Science ®Google Scholar
• Touch S, Suraratdecha C, Samnang C, et al. A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia. Vaccine 2010;28:4593-9
   PubMed Web of Science ®Google Scholar
• Yin Z, Beeler Asay GR, Zhang L, et al. An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China. Vaccine 2012;30:5569-77
   PubMed Web of Science ®Google Scholar
• Upreti SR, Janusz KB, Schluter WW, et al. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal. Am J Trop Med Hyg 2013;88:464-8
   PubMed Web of Science ®Google Scholar
• GAVI Alliance. Japanese encephalitis vaccine support guidelines. Available from: www.gavialliance.org/support/apply/ [Last accessed 18 April 2014]
   Google Scholar
• Elias C, Okwo-Bele JM, Fischer M. A strategic plan for Japanese encephalitis control by. 2015;Lancet Infect Dis 2009;9(1):7
   Google Scholar
• Senior K. Is Japanese encephalitis control achievable by 2013? Lancet Infect Dis 2008;8(9):534
   Web of Science ®Google Scholar
• Fischer M, Hills S, Staples E, et al. Japanese encephalitis prevention and control: advances, challenges, and new initiatives. In: Scheld WM, Hammer SM, Hughes JM, editors. Emerging Infections 8. ASM Press; Washington, DC: 2008. p. 93-124
   Google Scholar
• Centers for Disease Control and Prevention. Status of Japanese encephalitis surveillance and immunization – Asia and the Western Pacific, 2012. MMWR Morb Mortal Wkly Rep 2013;62(33):658-62
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes – Bangladesh, China, and India, 2006–2008. MMWR Morb Mortal Wkly Rep 2012;61(49):1008-11
   PubMedGoogle Scholar
• Wang SA, Hyde TB, Mounier-Jack S, et al. New vaccine introductions: Assessing the impact and the opportunities for immunization and health systems strengthening. Vaccine 2013;31S:B122-8
   Web of Science ®Google Scholar
• Bill & Melinda Gates Foundation. A big milestone for saving children. Available from: www.impatientoptimists.org/Posts/2013/10/A-Big-Milestone-for-Saving-Children [Last accessed 18 April 2014]
   Google Scholar
• World Health Organization. Global vaccine action plan 2011-2020. Available from: www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en [Last accessed 18 April 2014]
   Google Scholar